CAD 1.03
(1.98%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -24.25 Million USD | -96.41% |
2022 | -12.34 Million USD | 3.71% |
2021 | -12.82 Million USD | -482.92% |
2020 | -2.2 Million USD | -176.05% |
2019 | 2.89 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -959.23 Thousand USD | 94.23% |
2024 Q2 | 4.67 Million USD | 587.86% |
2023 FY | -24.25 Million USD | -96.41% |
2023 Q2 | -4.8 Million USD | -79.02% |
2023 Q4 | -16.61 Million USD | -1146.78% |
2023 Q3 | -1.33 Million USD | 72.26% |
2023 Q1 | -2.68 Million USD | 45.25% |
2022 FY | -12.34 Million USD | 3.71% |
2022 Q4 | -4.9 Million USD | -244.55% |
2022 Q3 | -1.42 Million USD | 48.6% |
2022 Q2 | -2.76 Million USD | 14.99% |
2022 Q1 | -3.25 Million USD | 32.89% |
2021 Q4 | -4.85 Million USD | 20.23% |
2021 Q1 | -565.06 Thousand USD | 77.92% |
2021 Q3 | -6.08 Million USD | -590.88% |
2021 FY | -12.82 Million USD | -482.92% |
2021 Q2 | -880.37 Thousand USD | -55.8% |
2020 Q3 | -100.73 Thousand USD | -169.02% |
2020 Q2 | 145.94 Thousand USD | -16.0% |
2020 Q1 | 173.75 Thousand USD | 108.58% |
2020 FY | -2.2 Million USD | -176.05% |
2020 Q4 | -2.55 Million USD | -2440.54% |
2019 Q3 | 1.42 Million USD | 0.0% |
2019 Q4 | -2.02 Million USD | -242.33% |
2019 FY | 2.89 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | -2.96 Million CAD | -718.105% |
CanadaBis Capital Inc. | 4.44 Million CAD | 645.721% |
Decibel Cannabis Company Inc. | -1.77 Million CAD | -1270.314% |
Delivra Health Brands Inc. | 876 Thousand CAD | 2868.784% |
Entourage Health Corp. | -46.16 Million CAD | 47.465% |
Lifeist Wellness Inc. | -14.12 Million CAD | -71.705% |
Cannara Biotech Inc. | 6.94 Million CAD | 449.217% |
Medicure Inc. | -922 Thousand CAD | -2530.645% |
PharmaCielo Ltd. | -16.29 Million CAD | -48.823% |
Rubicon Organics Inc. | -1.82 Million CAD | -1230.083% |
BioSyent Inc. | 6.46 Million CAD | 475.45% |
Voyageur Pharmaceuticals Ltd. | -1.39 Million CAD | -1633.125% |